雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

The Safety and Efficacy of Rapid Induction Therapy Using Tacrolimus for Severe Ulcerative Colitis Refractory to Steroid Therapy Mitsuyuki Murano 1,2 , Takuya Inoue 1 , Ken Narabayashi 1 , Sadaharu Noda 1 , Kumi Ishida 1 , Ken Kawakami 1 , Yousuke Abe 1 , Naoko Murano 1,2 , Satoshi Tokioka 1 , Eiji Umegaki 1 , Yutaro Egashira 3 , Kazuhide Higuchi 1 1Second Department of Internal medicine, Osaka Medical College, Takatsuki, Japan 2Murano Clinic, Osaka, Japan 3First Department of Pathology, Osaka Medical College, Takatsuki, Japan Keyword: タクロリムス , 急速導入療法 , 難治性潰瘍性大腸炎 , 有効性 , 安全性 pp.1957-1968
Published Date 2011/12/25
DOI https://doi.org/10.11477/mf.1403102744
  • Abstract
  • Look Inside
  • Reference

 Tacrolimus is the medicine whose the effectiveness including the induction of remission was demonstrated as a new therapy for intractable UC(ulcerative colitis). However, there are problems involved including blood trough level control and dose control methods. In this study, we examined the usefulness and safety of Tacrolimus rapid induction therapy for the short-term treatment effect of Tacrolimus on refractory ulcerative colitis The short-term response rate of the RI(rapid induction)therapy showed 83.3%(25/30)and very high effectiveness. Also, safety was confirmed without any serious adverse effects. It arrived at the optimal trough value in 93.3% of cases within its administration for four days. Also, the percent improvement〔CAI(clinical activity index)rate of decline in mortality〕four weeks later correlated with intermediary mean trough value of eyes for 2~3 weeks. Furthermore, what the primitive trough raised within five days after the administration was thought to be useful for symptom improvement so that a Middle trough value brought a stable value. FK506 is a medicine which induces remission, and brings about maintenance of refractory UC. However, there are problems involved in the dosing period and combined drug selection and the induction time of each case. Because there can be serious adverse effects, we examine and accommodate each case carefully, and it is necessary to treat severe cases based on a strict controls.


Copyright © 2011, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1219 印刷版ISSN 0536-2180 医学書院

関連文献

もっと見る

文献を共有